ASN Kidney Week 2024 – Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics From Bench to Potentially Curative Medicines

Overview

ASN Kidney Week 2024 – Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics From Bench to Potentially Curative Medicines offers a comprehensive on-demand digital program presenting the latest advances in gene therapy, genome editing, and RNA-based therapeutic approaches aimed at kidney disease treatment. This specialized conference captures state-of-the-art technological developments and clinical applications relevant to nephrology professionals.

On-demand nephrology education — accessible anytime, anywhere.

Agenda

This program includes a series of expert-led presentations focusing on genome engineering technologies and RNA-based therapeutics with potential clinical implications for kidney diseases. The content is structured to enhance understanding of contemporary genetic therapies and their translational value.

• Check In and Continental Breakfast —
• Welcome and Opening Remarks — Vishal Patel, MD
• Base Editing and Prime Editing: Technology and Toolbox for Correcting DNA Variants — Andrew Anzalone, MD, PhD
• Targeting the Kidneys for Gene Therapy — Matthew H. Wilson, MD, PhD
• Back to the Microbes: Searching for New and Diverse Gene-Editing Tools — Brian C. Thomas, PhD
• Break —
• Delivery Approaches to Carry Genetic Cargo to Kidneys — Eun ji Chung, PhD
• RNA Editing as a Novel Therapeutic Modality — Chikdu S. Shivalila, PhD
• AAV Vector-Mediated Gene Therapy for Alport Syndrome — Hiroyuki Nakai, MD, PhD
• Lunch (on your own) —
• CRISPR for the Treatment of Sickle Cell Disease — Alexis A. Thompson, MD, MPH
• Gene Therapy for Podocytopathies — Moin A. Saleem, MD, MBBS, MBChB, PhD
• RNA Interference in the Treatment of Kidney Stone Disease — John C. Lieske, MD, FASN
• Break —
• RNAi Drugs to Treat Hypertension — Rhian Touyz, MD, MBChB, PhD
• miRNA Therapeutics for Polycystic Kidney Disease — Edmund Chun Yu Lee, PhD
• Antisense Oligonucleotide Therapy for APOL1-Mediated Kidney Disease — Peter J. Greasley, PhD
• Antisense Oligonucleotide Therapy for Preeclampsia — S. Ananth Karumanchi, MD
• Closing Remarks — Opeyemi A. Olabisi, MD, PhD

Speakers

• Opeyemi A. Olabisi, MD, PhD
• Vishal Patel, MD
• Andrew Anzalone, MD, PhD
• Matthew H. Wilson, MD, PhD
• Brian C. Thomas, PhD
• Eun ji Chung, PhD
• Chikdu S. Shivalila, PhD
• Hiroyuki Nakai, MD, PhD
• Alexis A. Thompson, MD, MPH
• Moin A. Saleem, MD, MBBS, MBChB, PhD
• John C. Lieske, MD, FASN
• Rhian Touyz, MD, MBChB, PhD
• Edmund Chun Yu Lee, PhD
• Peter J. Greasley, PhD
• S. Ananth Karumanchi, MD

Target Audience

This program is designed for nephrologists, researchers, geneticists, and clinicians interested in genome editing and RNA-based therapeutic advancements applicable to kidney disease. It is suitable for professionals seeking to deepen their expertise in emerging molecular therapies and their nephrology applications.

Why This Topic Matters

ASN Kidney Week 2024 – Advances in Research Conference – Genome Engineering and RNA-Based Therapeutics From Bench to Potentially Curative Medicines addresses critical innovations in nephrology, emphasizing technologies with potential to transform care for patients with genetic and acquired kidney diseases. Understanding these advanced therapies supports clinical decision-making and research development within the specialty.

MedHub Central provides convenient on-demand access to this important nephrology conference, facilitating ongoing professional development and knowledge reinforcement in genome engineering and RNA therapeutics relevant to kidney health.